Jonathan M. Cohen - 03 Mar 2026 Form 4 Insider Report for 20/20 Biolabs, Inc.

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Jonathan Cohen
Issuer symbol: N/A
Transactions as of: 03 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 04 Mar 2026, 17:48:56 UTC
Previous filing: 19 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Cohen Jonathan M	Chief Executive Officer, Director, 10%+ Owner	C/O 20/20 BIOLABS, INC. 15810 GAITHER RD, SUITE 235, GAITHERSBURG	/s/ Jonathan Cohen	04 Mar 2026	0002111543

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction		Stock Option	Award		+352,936		$0.000000^*	352,936	03 Mar 2026	Common Stock	352,936	$3.39	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On March 3, 2026, the Reporting Person was granted a stock option for the purchase of 352,936 shares of common stock, which shall vest in equal quarterly installments over the following four (4) years, subject to the Reporting Person's continuous service to the Issuer.